Biomarkers and clinical interventions

Paradiso, A.
November 2013
Annals of Oncology;Nov2013 Supplement 8, Vol. 24 Issue suppl_8, pviii36
Academic Journal
No abstract available.


Related Articles

  • Breast Cancer Under Forty. Miller, Doriane C. // Chicago Citizen - Chicago Weekend Edition;11/20/2013, Vol. 43 Issue 46, p2 

    In this article, the author presents precautions against breast cancer for African –American women under the age of fourty. She mentions that African-American women exhibit particular genetic mutation which increases the chance of breast cancer disease among them. She suggests that women...

  • Mammograms: Worth it? Harrar, Sarí N. // Prevention;Mar2006, Vol. 58 Issue 3, p45 

    The article reports on a study that has found that mammograms are as effective at saving the lives of breast cancer patients as new treatments are. Researchers in the United States and the Netherlands examined statistics on detection, treatment and survival rates to determine what had caused the...

  • Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Rask, Lene; Balslev, Eva; Søkilde, Rolf; Høgdall, Estrid; Flyger, Henrik; Eriksen, Jens; Litman, Thomas // Cellular Oncology (2211-3428);Jun2014, Vol. 37 Issue 3, p215 

    Purpose: Therapeutic decisions in breast cancer are increasingly guided by prognostic and predictive biomarkers. Non-protein-coding microRNAs (miRNAs) have recently been found to be deregulated in breast cancers and, in addition, to be correlated with several clinico-pathological features. One...

  • MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours. Tanic, M; Andrés, E; M Rodriguez-Pinilla, S; Marquez-Rodas, I; Cebollero-Presmanes, M; Fernandez, V; Osorio, A; Benítez, J; Martinez-Delgado, B // British Journal of Cancer;11/12/2013, Vol. 109 Issue 10, p2724 

    Background:Hereditary breast cancer comprises 5-10% of all breast cancers. Mutations in two high-risk susceptibility genes, BRCA1 and BRCA2, along with rare intermediate-risk genes and common low-penetrance alleles identified, altogether explain no more than 45% of the high-risk breast cancer...

  • Local approaches to hereditary breast cancer. Cooper, B. T.; Murphy, J. O.; Sacchini, V.; Formenti, S. C. // Annals of Oncology;Nov2013 Supplement 8, Vol. 24 Issue suppl_8, pviii54 

    The diagnostic and local treatment modalities of hereditary breast cancer (HBC) are evolving based on emerging evidence from new imaging, radiotherapy and surgical studies. The optimal selection of diagnostic and therapeutic strategies for the individual HBC patient remains an area of active...

  • Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians? Morcos, Basem; Ahmad, Firas; Anabtawi, Iyad; Sba', Abdel; Shabani, Hisham; Yaseen, Rawya // Surgery Today;Jan2014, Vol. 44 Issue 1, p100 

    Introduction: Breast cancer-related lymphedema (LE) is relatively common. The aim of this study was to identify the risk factors involved in the development of this complication. Methodology: This was a cross-sectional study of breast cancer patients treated at our Center between 2004 and 2009....

  • Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients. Shimizu, Chikako; Kato, Tomoyasu; Tamura, Nobuko; Bando, Hiroko; Asada, Yoshimasa; Mizota, Yuri; Yamamoto, Seiichiro; Fujiwara, Yasuhiro // International Journal of Clinical Oncology;Feb2015, Vol. 20 Issue 1, p82 

    Background: Treatment-related infertility is one of the important quality-of-life issues in young breast cancer (YBC) patients. Although existing guidelines recommend supporting fertility preservation (FP) of YBC, the perceptions of reproductive specialists (RS) has not been evaluated. We...

  • Causal attributions to epidemiological risk factors and their associations to later psychological adjustment among Japanese breast cancer patients. Shino Oba; Naoyoshi Takatsuka; Chisato Nagata; Yasuko Nagao; Satoru Yamamoto; Chiken Shibuya // Supportive Care in Cancer;Jan2009, Vol. 17 Issue 1, p3 

    Abstract Goals  The objective of this study was to evaluate the causal attributions for breast cancer and their association with the subsequent psychological adjustment. Materials and methods  Sixty-three Japanese patients newly diagnosed with breast cancer were asked by an...

  • Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Quante, Anne S.; Whittemore, Alice S.; Shriver, Tom; Strauch, Konstantin; Terry, Mary B. // Breast Cancer Research;2012, Vol. 14 Issue 6, pR144 

    Introduction: Clinicians use different breast cancer risk models for patients considered at average and above-average risk, based largely on their family histories and genetic factors. We used longitudinal cohort data from women whose breast cancer risks span the full spectrum to determine the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics